Cargando…

Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study

BACKGROUND: The utility of generic health-related quality of life (HRQoL) questionnaires in patients with systemic lupus erythematosus (SLE) is uncertain. We compared the performance of generic (SF36) and specific (SLEQOL) HRQoL surveys by examining their associations with the Global Rating of Chang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Louthrenoo, Worawit, Kasitanon, Nuntana, Morand, Eric, Kandane-Rathnayake, Rangi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954627/ https://www.ncbi.nlm.nih.gov/pubmed/31924267 http://dx.doi.org/10.1186/s13075-020-2095-4

Ejemplares similares

Predicting factors of adverse pregnancy outcomes in Thai patients with systemic lupus erythematosus: A STROBE-compliant study
por: Louthrenoo, Worawit, et al.
Publicado: (2021)

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study
por: Louthrenoo, Worawit, et al.
Publicado: (2021)

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
por: Northcott, Melissa, et al.
Publicado: (2022)

The Correlation of Muscle Biopsy Scores with the Clinical Variables in Idiopathic Inflammatory Myopathies
por: Wangkaew, Suparaporn, et al.
Publicado: (2016)

Clinical associations of cognitive dysfunction in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2023)

Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus
por: Godsell, Jack, et al.
Publicado: (2016)

Performance of the Existing Classification Criteria for Gout in Thai Patients Presenting With Acute Arthritis
por: Jatuworapruk, Kanon, et al.
Publicado: (2016)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2018)

Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma
por: Ketpueak, Thanika, et al.
Publicado: (2022)

Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study
por: Kandane-Rathnayake, Rangi, et al.
Publicado: (2021)

Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL)
por: Ahmad Pouzi, Nur Aqeelah, et al.
Publicado: (2023)

Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2019)

Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2022)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2018)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis
por: Louthrenoo, Worawit, et al.
Publicado: (2011)

Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study
por: Maneeton, Benchalak, et al.
Publicado: (2013)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Independent association of glucocorticoids with damage accrual in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2016)

‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study
por: Kandane-Rathnayake, Rangi, et al.
Publicado: (2022)

Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity
por: Wee, Christina C, et al.
Publicado: (2008)

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
por: Golder, Vera, et al.
Publicado: (2017)

Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort
por: Golder, Vera, et al.
Publicado: (2016)

Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis
por: Osiri, Manathip, et al.
Publicado: (2009)

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
por: Lin, Emily, et al.
Publicado: (2019)

How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review
por: Papaioannou, Diana, et al.
Publicado: (2011)

Quality of Life in Mexican Older Adults: Factor Structure of the SF-36 Questionnaire
por: Aguirre, Susana Ivonne, et al.
Publicado: (2022)

Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis
por: Vincent, Fabien B, et al.
Publicado: (2018)

Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)

Validation of the Mongolian version of the SF-36v2 questionnaire for health status assessment of Mongolian adults
por: Nakao, Motoyuki, et al.
Publicado: (2016)

Targeting DORIS Remission and LLDAS in SLE: A Review
por: Parra Sánchez, Agner R., et al.
Publicado: (2023)

Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis
por: Zhu, Yu-Xia, et al.
Publicado: (2016)

Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)
por: Williams-Hall, Rebecca, et al.
Publicado: (2022)

Clinical Features and Treatment Outcomes of Bone-Joint Infection Between Bacteria and Mycobacterium Tuberculosis
por: Chumsaengsri, Chumsaeng, et al.
Publicado: (2017)

Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires
por: Janani, K, et al.
Publicado: (2018)

Health-related quality of life in Switzerland: normative data for the SF-36v2 questionnaire
por: Roser, Katharina, et al.
Publicado: (2019)

Health-related quality of life among thalassemia patients in Bangladesh using the SF-36 questionnaire
por: Hossain, Md Jubayer, et al.
Publicado: (2023)

Validation of the SF-36 in patients with endometriosis
por: Stull, Donald E., et al.
Publicado: (2013)

Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease
por: Iudici, Michele, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ssejld1rtf71rskkv83oqrqlat